Profil
Mark Sard is the founder.
He founded Frontier Equities VC LLC in 2011 as a Principal.
He is currently working as a Director at Lirum Therapeutics, Inc. since 2022.
Previously, he worked as a Director at Stemline Therapeutics, Inc. from 2018 to 2020.
Mr. Sard completed his undergraduate degree at the University of Pennsylvania.
Aktiva positioner av Mark Sard
| Företag | Position | Start |
|---|---|---|
| LIRUM THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2022-11-01 |
Frontier Equities VC LLC
Frontier Equities VC LLC Investment ManagersFinance Frontier Equities seeks investment opportunities in early to mid-stage companies located in United States. The firm focuses across a wide array of sectors. | Grundare | 2011-01-01 |
Tidigare kända positioner av Mark Sard
| Företag | Position | Slut |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2020-06-10 |
Mark Sards utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Stemline Therapeutics, Inc.
Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Frontier Equities VC LLC
Frontier Equities VC LLC Investment ManagersFinance Frontier Equities seeks investment opportunities in early to mid-stage companies located in United States. The firm focuses across a wide array of sectors. | Finance |
Lirum Therapeutics, Inc.
Lirum Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on the treatment of debilitating diseases | Health Technology |
















